Lexapro is an effective antidepressant that treats depression and certain mood conditions. Drug usage Belong to a group of medicines known as Selective Serotonin Reuptake Inhibitors, Lexapro brings in changes in the chemicals in the brain that causes depression. How taken Lexapro has to be taken with a full glass of water every day. Once the medicine is prescribed for your mood changes, follow strictly the prescription.
Consumer information about the medication ESCITALOPRAM - ORAL Lexapro, includes side effects, drug interactions, recommended dosages, and storage.
![lexapro side effects 10mg](http://images.ddccdn.com/images/pills/nlm/200000937.jpg)
- Learn about the potential side effects of Lexapro escitalopram. Includes common and rare side effects information for consumers and healthcare professionals.
- Find a comprehensive guide to possible side effects when taking Lexapro Escitalopram Oxalate for Professionals, Patients, and Caregivers.
- Lexapro 10 mg. Lexapro Escitalopram is used for treating depression and anxiety.
- Drug information on Lexapro escitalopram, includes drug pictures, side effects, drug interactions, directions for use, symptoms of overdose, and what to avoid.
Not all side effects for Lexapro may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here. For the Consumer Applies to escitalopram: oral solution, oral tablet In addition to its needed effects, some unwanted effects may be caused by escitalopram (the active ingredient contained in Lexapro). In the event that any of these side effects do occur, they may require medical attention. You should check with your doctor immediately if any of these side effects occur when taking escitalopram: Some of the side effects that can occur with escitalopram may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional: For Healthcare Professionals Applies to escitalopram: oral solution, oral tablet General Side effects have been reported to be generally mild and transient. They are most common during the first 2 weeks of treatment and decrease in intensity and frequency with continued treatment. They generally do not lead to treatment cessation. The overall incidence of rates of side effects in trials with patients treated with escitalopram (the active ingredient contained in Lexapro) 10 mg per day (66%) was similar to placebo-treated patients (61%); the incidence rate in the group treated with escitalopram 20 mg per day was greater (86%). Common side effects that occurred in the 20 mg per day group with an incidence approximately twice that of the 10 mg group and approximately twice that of the placebo group included insomnia, diarrhea, dry mouth, somnolence, dizziness, increased sweating, constipation, fatigue, and indigestion.[Ref ] Psychiatric Antidepressants may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment. An increased risk of suicidal thinking and behavior in children, adolescents, and young adults (aged 18 to 24 years) with major depressive disorder (MDD) and other psychiatric disorders has been reported with short-term use of antidepressant drugs. Adult and pediatric patients receiving antidepressants for MDD, as well as for psychiatric and nonpsychiatric indications, have reported symptoms that may be precursors to emerging suicidality, including anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia, hypomania, and mania. Causality has not been established.[Ref ] Very common (10% or more): Insomnia Common (1% to 10%): Abnormal dreams, agitation, anxiety, nervousness, restlessness Uncommon (0.1% to 1%): Abnormal thinking, aggravated depression, aggressive reaction, aggravated restlessness, alcohol problem, apathy, bruxism, confusion, confusional state, depersonalization, depression, emotional lability, excitability, feeling unreal, forgetfulness, hallucination, hypomania, irritability, jitteriness, obsessive-compulsive disorder, panic reaction, paroniria, sleep disorder, suicide attempt, tics Frequency not reported: Mania, suicidal ideation Postmarketing reports: Acute psychosis, anger, delirium, delusion, disorientation, non-accidental overdose, mood swings, nightmare, psychotic disorder, withdrawal syndrome[Ref ] Nervous system Convulsions (including grand mal convulsions) have been reported with racemic citalopram. Potentially life-threatening serotonin syndrome has been reported with SSRIs and SNRIs as monotherapy, but particularly with concomitant use of other serotonergic drugs and drugs that impair the metabolism of serotonin. Serotonin syndrome has been reported with racemic citalopram. At least one case of escitalopram-induced paroxysmal dystonia has been reported in the literature. A 44-year-old woman developed paroxysmal cervical-cranial dystonia after receiving several days of treatment with escitalopram (the active ingredient contained in Lexapro) The paroxysmal movement disorders were characterized by cervical and oral contracture with sustained and painful laterocollis and twisting tongue movements. The episodes occurred several times a day lasting for several minutes and would resolve spontaneously. The day after escitalopram was discontinued, the paroxysmal symptoms resolved without recurrence.[Ref ] Very common (10% or more): Headache, somnolence Common (1% to 10%): Dizziness, paraesthesia, tremor Uncommon (0.1% to 1%): Amnesia, ataxia, carpal tunnel syndrome, cerebrovascular disorder, concentration impairment, dysesthesia, disequilibrium, dysgeusia, dystonia, hyperkinesia, hyperreflexia, hypertonia, hypoesthesia, lethargy, lightheadedness, migraine, nerve root lesion, neuralgia, neuropathy, paralysis, sedation, syncope Rare (less than 0.1%): Serotonin syndrome Frequency not reported: Abnormal gait, cerebrovascular accident, choreoathetosis, convulsions, dyskinesia, extrapyramidal disorder, grand mal convulsions, myoclonus, movement disorder, psychomotor restlessness/akathisia Postmarketing reports: Dysarthria, neuroleptic malignant syndrome, nystagmus, parkinsonism, tardive dyskinesia[Ref ] Cardiovascular Cases of QT interval prolongation and ventricular arrhythmias reported in postmarketing experience were predominantly in females, with hypokalemia, or with pre-existing QT interval prolongation or other cardiac diseases. Postural hypotension has been reported with other SSRIs.[Ref ] Common (1% to 10%): Palpitation Uncommon (0.1% to 1%): Abnormal ECG, aggravated hypertension, angina pectoris, bradycardia, chest tightness, chest pain, flushing, hot flush, hypertension, hypotension, myocardial infarction, myocardial ischemia, myocarditis, edema, edema of extremities, peripheral edema, peripheral ischemia, tachycardia, varicose vein, vein disorder, vein distended Frequency not reported: Orthostatic hypotension Postmarketing reports: Atrial fibrillation, cardiac failure, prolonged QT, deep vein thrombosis, hypertensive crisis, phlebitis, thrombosis, torsades de pointes, ventricular arrhythmia, ventricular tachycardia[Ref ] Gastrointestinal Very common (10% or more): Nausea Common (1% to 10%): Abdominal pain, constipation, diarrhea, dry mouth, dyspepsia, flatulence, indigestion, toothache, vomiting Uncommon (0.1% to 1%): Abdominal cramp, abdominal discomfort, belching, bloating, change in bowel habit, colitis, enteritis, epigastric discomfort, gastritis, gastrointestinal bleeding, gastrointestinal hemorrhage (including rectal hemorrhage) gastroesophageal reflux, hemorrhoids, heartburn, increased stool frequency, irritable bowel syndrome, melena, periodontal destruction, tooth disorder, ulcerative colitis, ulcerative stomatitis Frequency not reported: Gastroenteritis Postmarketing reports: Dysphagia, pancreatitis, stomatitis[Ref ] Metabolic Common (1% to 10%): Decreased appetite, increased appetite, weight increased Uncommon (0.1% to 1%): Abnormal glucose tolerance, carbohydrate craving, diabetes mellitus, gout, hypercholesterolemia, hyperglycemia, hyperlipemia, thirst, weight decreased Frequency not reported: Anorexia, hyponatremia Postmarketing reports: Hypoglycemia, hypokalemia[Ref ] Numerous cases of hyponatremia have been reported following treatment with an SSRI. Risk factors for the development of SSRI- associated hyponatremia including advanced age, female gender, concomitant use of diuretics, low body weight, and lower baseline serum sodium levels have been identified. Hyponatremia tends to develop within the first few weeks of treatment (range 3 to 120 days) and typically resolves within 2 weeks (range 48 hours to 6 weeks) after therapy has been discontinued with some patients requiring treatment. The proposed mechanism for the development of hyponatremia involves SIADH via release of antidiuretic hormone. A 62-year-old woman developed hyponatremia approximately 3- weeks after initiating treatment with escitalopram. Following discontinuation of the drug and administration of intravenous normal saline solution, the patient's serum sodium and serum and urine osmolality returned to normal levels. In a similar case, hyponatremia developed in a 75-year-old woman five days after initiating treatment with escitalopram. Following discontinuation of escitalopram serum sodium levels returned to normal values over a period of 5 days. The authors suggest that the risk of hyponatremia is highest during the initial weeks of treatment and is higher in women than in men, in patients 65 years of age or older, and in patients receiving multiple drugs that may also cause hyponatremia.[Ref ] Other Common (1% to 10%): Fatigue, pyrexia Uncommon (0.1% to 1%): Abscess, accidental injury, asthenia, bite, burn, deafness, earache, ear disorder, ear infection not otherwise specified, facial edema, fall, food poisoning, fractured neck of femur, hernia, inflicted injury (unintended injury), malaise, otitis externa, otosalpingitis, rigors, sting, surgical intervention, tinnitus, traumatic hematoma, vertigo Postmarketing reports: Injury not otherwise specified, spontaneous abortion[Ref ] Genitourinary Very common (10% or more): Ejaculation disorder Common (1% to 10%): Anorgasmia, decreased libido, ejaculation failure, impotence, menstrual disorder, vaginal bleeding Uncommon (0.1% to 1%): Amenorrhea, atrophic vaginitis, breast pain, cystitis, delayed ejaculation, dysmenorrhea, dysuria, genital infection, genital moniliasis, intermenstrual bleeding, loss of libido, menopausal symptoms, menorrhagia, menstrual cramps, metrorrhagia, micturition disorder, micturition frequency, nocturia, ovarian cyst, polyuria, postmenopausal bleeding, premenstrual tension, prostatic disorder, sexual function abnormality, unintended pregnancy, urinary incontinence, urinary retention, urinary tract infection, uterine fibroid, vaginal candidiasis, vaginal hemorrhage, vaginitis Frequency not reported: Galactorrhea, priapism[Ref ] Urinary retention and galactorrhea have been reported with other SSRIs. The estimates of the incidence of untoward sexual experience and performance may underestimate their actual incidence, partly because patients and physicians may be reluctant to discuss this issue.[Ref ] Dermatologic Common (1% to 10%): Increased sweating Uncommon (0.1% to 1%): Acne, aggravated psoriasis, alopecia, cellulitis, dry skin, eczema, erythematous rash, fungal dermatitis, furunculosis, hematomas, lichenoid dermatitis, onychomycosis, pruritus, purpura, pustular rash, rash, scar, skin disorder, urticaria, verruca Frequency not reported: Angioedema, ecchymosis Postmarketing reports: Epidermal necrolysis, erythema multiforme, Stevens Johnson syndrome, toxic epidermal necrolysis[Ref ] Angioedema has been reported with racemic citalopram.[Ref ] Endocrine Frequency not reported: Inappropriate antidiuretic hormone secretion (SIADH) Postmarketing reports: Hyperprolactinemia[Ref ] Hematologic Uncommon (0.1% to 1%): Anemia, hypochromic anemia, leucopenia Frequency not reported: Thrombocytopenia Postmarketing reports: Agranulocytosis, aplastic anemia, decreased prothrombin, hemolytic anemia, idiopathic thrombocytopenia purpura, increased INR[Ref ] Hepatic Uncommon (0.1% to 1%): Bilirubinemia, hepatic enzymes increased Postmarketing reports: Fulminant hepatitis, hepatic failure, hepatic necrosis, hepatitis, increased bilirubin[Ref ] Hypersensitivity Uncommon (0.1% to 1%): Aggravated allergy, allergic reactions Frequency not reported: Anaphylaxis Postmarketing reports: Hypersensitivity not otherwise specified, photosensitivity reaction[Ref ] Immunologic Common (1% to 10%): Influenza-like symptoms Uncommon (0.1% to 1%): Bacterial infection, herpes simplex, herpes zoster, infection, moniliasis, parasitic infection, tuberculosis[Ref ] Musculoskeletal Common (1% to 10%): Arthralgia, back pain, myalgia, neck/shoulder pain Uncommon (0.1% to 1%): Arthritis, arthropathy, arthrosis, bursitis, costochondritis, fibromyalgia, ischial neuralgia, jaw stiffness, leg pain, limb pain, leg cramps, lumbar disc lesion, muscle contractions, muscle cramp, muscle spasms, muscle stiffness, muscle tightness, muscle weakness, myopathy, osteoporosis, plantar fasciitis, tendinitis, tenosynovitis, tetany, twitching Postmarketing reports: Rhabdomyolysis[Ref ] Epidemiological studies, primarily in patients aged 50 years or older, have shown an increased risk of bone fractures in patients receiving SSRIs or TCAs.[Ref ] Ocular Uncommon (0.1% to 1%): Abnormal accommodation, abnormal vision, blepharospasm, blurred vision, dry eyes, eye infection, eye irritation, eye pain, mydriasis, ocular hemorrhage, visual disturbance, xerophthalmia Postmarketing reports: Angle closure glaucoma, diplopia[Ref ] Oncologic Uncommon (0.1% to 1%): Cyst, female breast neoplasm, ovarian cyst[Ref ] Renal Uncommon (0.1% to 1%): Pyelonephritis, renal calculus Postmarketing reports: Acute renal failure[Ref ] Respiratory Common (1% to 10%): Pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, yawning Uncommon (0.1% to 1%): Asthma, bronchitis, coughing, dyspnea, epistaxis, laryngitis, nasal congestion, nasopharyngitis, pneumonia, respiratory tract infection, shortness of breath, sinus congestion, sinus headache, sleep apnea, snoring, tracheitis, throat tightness Postmarketing reports: Pulmonary embolism, pulmonary hypertension of the newborn[Ref ] References 1. Cerner Multum, Inc. "Australian Product Information." O 0 2. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0 3. "Product Information. Lexapro (escitalopram)." Forest Pharmaceuticals, St. Louis, MO. 4. Davidson JR, Bose A, Wang Q "Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder." J Clin Psychiatry 66 (2005): 1441-6 5. Jacob S, Spinler SA "Hyponatremia associated with selective serotonin-reuptake inhibitors in older adults." Ann Pharmacother 40 (2006): 1618-22 6. Covyeou JA, Jackson CW "Hyponatremia associated with escitalopram." N Engl J Med 356 (2007): 94-5 Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.','url':'http://www.drugs.com/sfx/lexapro-side-effects.html','og_descr':'Learn about the potential side effects of Lexapro (escitalopram). Includes common and rare side effects information for consumers and healthcare professionals.
![lexapro side effects 10mg](http://ketoconazole200mg.net/uploads/21011/zoloft-vs-lexapro-side-effects.jpg)
Lexapro 10 mg
![lexapro side effects 10mg](http://trim9x.net78.net/images/amoxicillin-epocrates.jpg)
Find patient medical information for escitalopram oxalate oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Information about what to expect, side effects, reviews, pharmacist tips, benefits, downsides, and uses of Lexapro Escitalopram, from medical experts and people.
![Lexapro Side Effects](http://www.drugs.com/img/social/ddc-facebook-icon.png)
![lexapro side effects 10mg](http://images.ddccdn.com/images/pills/nlm/200000438.jpg)
![lexapro side effects 10mg](http://3.bp.blogspot.com/-qGs8nszkRCY/Tyxa1F-kCeI/AAAAAAAAABM/oxz0TDuS1KU/s200/lexapro-5mg.jpg)